BXP
34
4
MUR
38
2
RSG
53
2
FSLR
49
-3
A
54
3
HON
52
-3
PNR
50
3
IP
48
-2
COST
54
-2
XOM
44
7
CAG
46
5
UA
45
7
PCG
40
-3
AAPL
46
-2
OXY
44
4
SE
61
-7
DGX
37
2
MLM
31
2
UNP
43
14
SYF
64
2
BXP
34
4
MUR
38
2
RSG
53
2
FSLR
49
-3
A
54
3
HON
52
-3
PNR
50
3
IP
48
-2
COST
54
-2
XOM
44
7
CAG
46
5
UA
45
7
PCG
40
-3
AAPL
46
-2
OXY
44
4
SE
61
-7
DGX
37
2
MLM
31
2
UNP
43
14
SYF
64
2
Financhill
Back

Cassava Sciences Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
31

SAVA
Cassava Sciences

Last Price:
$2.62
Seasonality Move:
20.94%
Buy
53

SRPT
Sarepta Therapeutics

Last Price:
$118.76
Seasonality Move:
6.9%
Sell
31
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $2.73. The Score for SAVA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.43. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $2.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.97 Sell
Relative Strength Index (14 RSI): 28.97 Sell
Chaikin Money Flow: 1748030 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.44 - 2.94) Buy
Bollinger Bands (100): (8.14 - 31.62) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 41.84 Sell
Chaikin Money Flow: -925539 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.93 - 126.87) Sell
Bollinger Bands (100): (117.66 - 132.98) Sell

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.79 Sell
20-day SMA: 2.62 Buy
50-day SMA: 11.44 Sell
200-day SMA: 19.88 Sell
8-day EMA: 2.78 Sell
20-day EMA: 3.73 Sell
50-day EMA: 9.48 Sell
200-day EMA: 18.39 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 124.23 Sell
20-day SMA: 123.09 Sell
50-day SMA: 121.89 Sell
200-day SMA: 129.6 Sell
8-day EMA: 123.35 Sell
20-day EMA: 123.39 Sell
50-day EMA: 123.57 Sell
200-day EMA: 125.67 Sell

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.88 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.83 per share, and an increase next year of $4.82 per share.

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):